Pharmaceutical Research
Manufacture, supply agreement for monoclonal antibody TRX4 signed with Abbott
Published in Obesity and Diabetes Week, January 2nd, 2006
Under the terms of the agreement, Abbott will perform scale-up and GMP manufacturing of TRX4 for use in clinical trials, as well as supply commercial-grade material to support regulatory submissions and potential commercial launch. Financial terms were not disclosed.
"With the recent efficacy data with TRX4 in type 1 diabetes and our ongoing clinical trials in subjects with type 1 diabetes and psoriasis, this agreement positions TolerRx to ensure adequate supply of TRX4 for pivotal clinical studies and, if approved, for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
High sugar intake is linked to lower AIR, indicating poor beta cell function and diabetes risk - Diabetes Pathogenesis
Lower catecholamine-induced lipolysis and HSL expression are linked to obesity - Diabetes Pathogenesis
Prediabetic rats lacking CCK-1 receptors display altered taste functions - Diabetes Pathogenesis
The mechanisms behind diabetes and hypertension onset in hereditary obesity are presented - Obesity Epidemiology
Epicardial fat is significantly related to obesity-related insulin resistance - Adverse Drug Reaction
Exenatide lowered plasma glucose when given by continuous SC infusion over 23 h - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
